Epsilon Healthcare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Epsilon Healthcare hat ein Gesamteigenkapital von A$9.2M und eine Gesamtverschuldung von A$2.5M, was einen Verschuldungsgrad von 27.1% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen A$17.8M bzw. A$8.7M.

Wichtige Informationen

27.1%

Verhältnis von Schulden zu Eigenkapital

AU$2.49m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	AU$301.46k
Eigenkapital	AU$9.16m
Gesamtverbindlichkeiten	AU$8.66m
Gesamtvermögen	AU$17.82m

Jüngste Berichte zur Finanzlage

Recent updates

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Oct 13

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Jun 30

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Sep 26

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Jun 13

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Feb 27

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: EPNDie kurzfristigen Aktiva des Unternehmens (A$3.1M) decken seine kurzfristigen Passiva (A$5.7M) nicht.

Langfristige Verbindlichkeiten: EPNDie kurzfristigen Vermögenswerte des Unternehmens (A$3.1M) übersteigen seine langfristigen Verbindlichkeiten (A$2.9M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: EPNDie Nettoverschuldung im Verhältnis zum Eigenkapital (23.8%) wird als zufriedenstellend angesehen.

Schulden abbauen: EPNDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 27.1% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: EPN hat auf der Grundlage seines derzeitigen freier Cashflows weniger als ein Jahr Liquiditätsspielraum.

Vorhersage Cash Runway: EPN hat weniger als ein Jahr Liquidität, wenn der freie Cashflow weiterhin mit historischen Raten von 9.3% pro Jahr wächst.

Epsilon Healthcare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Recent updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen